Vertex Pharmaceuticals earnings were -$535.6M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest VRTX earnings report on Dec 31, 2024 announced Q4 2024 earnings of $913.0M, down 12.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, VRTX reported annual earnings of -$535.6M, with -114.8% growth. The next VRTX earnings date is May 5, 2025.
Vertex Pharmaceuticals Earnings Reports & History FAQ
What were Vertex Pharmaceuticals's earnings last quarter?
On VRTX's earnings call on Invalid Date, Vertex Pharmaceuticals (NASDAQ: VRTX) reported Q4 2024 earnings per share (EPS) of $3.53, up 6.12% year over year. Total VRTX earnings for the quarter were $913.00 million. In the same quarter last year, Vertex Pharmaceuticals's earnings per share (EPS) was $3.76.
The next VRTX earnings date is Invalid Date. Add VRTX to your watchlist to be reminded of Vertex Pharmaceuticals's next earnings date.
What was VRTX's earnings growth in the past year?
As of Vertex Pharmaceuticals's earnings date in Invalid Date, Vertex Pharmaceuticals's earnings has grown year over year. VRTX earnings in the past year totalled -$535.60 million.
Is Vertex Pharmaceuticals profitable or losing money?
As of the last Vertex Pharmaceuticals earnings report, Vertex Pharmaceuticals is currently losing money. Vertex Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$535.60 million, a 114.8% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.